Quality writing is a great AI use case, if you control it
Deviations and CAPAs are text-heavy and time-consuming. AI can help teams draft faster, but only if you design the use case to protect data integrity and inspection readiness.
What to allow the AI to do
Draft structure. Create a first draft using approved templates and standard phrasing.
Improve clarity. Suggest clearer language, consistent terminology, and better sequencing.
Summarize facts. Summarize an approved set of inputs, not open-ended data dumps.
What the AI must not do
Invent facts. It cannot guess root cause, dates, or actions.
Make decisions. It cannot classify severity or approve closure.
Use uncontrolled sources. It cannot pull “best practice” from the internet for regulated actions.
Controls that make it defensible
Use data minimization, restrict sources to approved repositories, require citations to internal references, and enforce human review with a recorded outcome. Store prompt version, model version, and approved output as part of the record.
This approach keeps the speed benefits while keeping QA in control.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.